Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors

Journal of Gene Medicine

Volumn 7, Issue 7, 2005, Pages 918-925

  Moore, Michael D ^a   McGarvey, Michael J ^a   Russell, Rebecca A ^a   Cullen, Bryan R ^b   McClure, Myra O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HBV; RNAi; Viral vectors

Indexed keywords

CELL DNA; CORE PROTEIN; DNA DIRECTED RNA POLYMERASE III; GENOMIC RNA; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VIRUS PROTEIN; VIRUS RNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANTIGEN EXPRESSION; ARTICLE; CELL CLONE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA INTEGRATION; EMBRYO; FIBROBLAST CULTURE; GENE CASSETTE; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSDUCTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; MEDICAL RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; SPUMA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VIRULENCE;

BASE SEQUENCE; CELLS, CULTURED; DEPENDOVIRUS; GENETIC VECTORS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; RETROVIRIDAE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC; TRANSFECTION; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; HEPATITIS B VIRUS; HUMAN SPUMARETROVIRUS;

EID: 22544447827     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.739     Document Type: Article

References (45)

1. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
2. Caplen NJ, Parrish S, Imani F, et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A 2001; 98: 9742-9747.
3. Hammond SM, Bernstein E, Beach D, et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404: 293-296.
4. Svoboda P, Stein P, Hayashi H, et al. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 2000; 127: 4147-4156.
5. Bernstein E, Caudy AA, Hammond SM, et al. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363-366.
6. Martinez J, Patkaniowska A, Urlaub H, et al. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002; 110: 563-574.
7. Schwarz DS, Hutvagner G, Haley B, et al. Evidence that siRNAS function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell 2002; 10: 537-548.
8. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002; 418: 430-434.
9. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 2002; 169: 5196-5201.
10. Hu WY, Myers CP, Kilzer JM, et al. Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002; 12: 1301-1311.
11. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999; 17: 1730-1733.
12. Hollinger FB, Liang TJ. Hepatitis B virus. In Fields Virology, Knipe DM, Howley PM (eds). Lippincott Williams & Wilkins: Philadelphia, 2001; 2971-3036.
13. Ponnazhagan S, Mukherjee P, Yoder MC, et al. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 1997; 190: 203-210.
14. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-1737.
15. Hamasaki K, Nakao K, Matsumoto K, et al. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 2003; 543: 51-54.
16. Klein C, Bock CT, Wedemeyer H, et al. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 2003; 125: 9-18.
17. McCaffrey AP, Nakai H, Pandey K, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003; 21: 639-644.
18. Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003; 37: 764-770.
19. Zhang XN, Xiong W, Wang JD, et al. siRNA-mediated inhibition of HBV replication and expression. World J Gastroenterol 2004; 10: 2967-2971.
20. Ni Q, Chen Z, Yao HP, et al. Inhibition of human La protein by RNA interference downregulates hepatitis B virus mRNA in 2.2.15 cells. World J Gastroenterol 2004; 10: 2050-2054.
21. Ying C, De Clercq E, Neyts J. Selective inhibition of hepatitis B virus replication by RNA interference. Biochem Biophys Res Commun 2003; 309: 482-484.
22. Liu J, Guo Y, Xue CF, et al. Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells. World J Gastroenterol 2004; 10: 1898-1901.
23. Chen Y, Du D, Wu J, et al. Inhibition of hepatitis B virus replication by stably expressed shRNA. Biochem Biophys Res Commun 2003; 311: 398-404.
24. Ponnazhagan S, Erikson D, Kearns WG, et al. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther 1997; 8: 275-284.
25. Hill CL, Bieniasz PD, McClure MO. Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol 1999; 80: 2003-2009.
26. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
27. Chisari FV, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145-1156.
28. Heinkelein M, Dressler M, Jarmy G, et al. Improved primate foamy virus vectors and packaging constructs. J Virol 2002; 76: 3774-3783.
29. Chung JH, Whiteley M, Felsenfeld G. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 1993; 74: 505-514.
30. Yang S, Delgado R, King SR, et al. Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther 1999; 10: 123-132.
31. Rasheed SWA, Nelson-Rees WA, Toth EM, et al. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 1974; 33: 1027-1033.
32. Riggs JL, McAllister RM, Lennette EH. Immunofluorescent studies of RD-114 virus replication in cell culture. J Gen Virol 1974; 25: 21-29.
33. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 1987; 84: 1005-1009.
34. Patton G, Erlwein O, McClure MO. Cell-cycle dependence of foamy virus vectors. J Gen Virol 2004; 85: 2925-2930.
35. Pietschmann T, Heinkelein M, Heldmann M, et al. Foamy virus capsids require the cognate envelope protein for particle export. J Virol 1999; 73: 2613-2621.
36. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
37. Sambrook J, Fritsch ER, Maniatis T. Molecular Cloning: A Laboratory Manual (2nd edn), Cold Spring Harbor Press: Cold Spring Harbor, 1989.
38. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15: 188-200.
39. Harborth J, Elbashir SM, Vandenburgh K, et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 2003; 13: 83-105.
40. Gitlin L, Andino R. Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing. J Virol 2003; 77: 7159-7165.
41. Trobridge G, Russell DW. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 2004; 78: 2327-2335.
42. McManus MT, Petersen CP, Haines BB, et al. Gene silencing using micro-RNA designed hairpins. RNA 2002; 8: 842-850.
43. Bridge AJ, Pebernard S, Ducraux A, et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263-264.
44. Stojdl DF, Lichty B, Knowles S, et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 2000; 6: 821-825.
45. Robek MD, Wieland SF, Chisari FV. Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol 2002; 76: 3570-3574.